|
|
Volumn 23, Issue 9, 2002, Pages 428-429
|
|
Cancer immunotherapy: Novel strategies and clinical experiences
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
AS 02;
CANCER VACCINE;
GAMMA INTERFERON;
GLYCOPROTEIN GP 100;
ISA 51;
MELAN A;
SODIUM CHLORIDE;
TELOMERASE;
UNCLASSIFIED DRUG;
CANCER IMMUNOTHERAPY;
CANCER SURVIVAL;
CLINICAL TRIAL;
CONFERENCE PAPER;
CYTOTOXIC T LYMPHOCYTE;
DENDRITIC CELL;
DOSE RESPONSE;
GRAFT VERSUS HOST REACTION;
HUMAN;
IMMUNE RESPONSE;
KIDNEY CARCINOMA;
NATURAL KILLER CELL;
PANCREAS CARCINOMA;
STEM CELL TRANSPLANTATION;
T LYMPHOCYTE ACTIVATION;
TH1 CELL;
TREATMENT OUTCOME;
VACCINATION;
CANCER VACCINES;
CLINICAL TRIALS;
DENDRITIC CELLS;
GRAFT VS HOST DISEASE;
HISTOCOMPATIBILITY ANTIGENS CLASS I;
HISTOCOMPATIBILITY ANTIGENS CLASS II;
HUMANS;
IMMUNOTHERAPY;
NEOPLASMS;
PEPTIDES;
STEM CELL TRANSPLANTATION;
|
|
EID: 0036715412
PISSN: 14714906
EISSN: None
Source Type: Journal
DOI: 10.1016/S1471-4906(02)02300-1 Document Type: Conference Paper |
|
Times cited : (6)
|
|
References (6)
|
